25
Mar 2026
A new paper in Genome Biology and Evolution, published by Oxford University Press, indicates that while the COVID-19 virus has developed rapidly since 2019, it has done so within limited genetic channels.
25
Mar 2026
The risk of developing early cardiovascular disease or dying from cardiovascular disease by the age of 28 was about 4.6 times higher among people born to mothers who had a placental abruption during their pregnancy.
25
Mar 2026
Researchers have determined how a key protein activates brown fat by expanding blood vessels and nerves in the heat-generating tissue.
25
Mar 2026
Sleep apps offer data-driven insights for better rest, but may increase anxiety in some users. Study reveals varied effects based on demographics and insomnia.
25
Mar 2026
Health insurance is out of reach for millions of Americans this year. Many are making difficult decisions about how to pay for coverage amid the loss of Affordable Care Act subsidies and nosebleed-high premiums.
25
Mar 2026
Mount Sinai researchers have published the first organ-wide human skin spatial atlas from across the body.
25
Mar 2026
Investigating collagen peptides, this review explores their role in skin aging, assessing clinical evidence and the mechanisms behind their potential benefits.
25
Mar 2026
Research links higher dietary calcium and dairy consumption to reduced odds of metabolic syndrome, highlighting potential dietary interventions for health.
25
Mar 2026
Stress is a constant companion in the oncologist's office. It appears at the time of diagnosis, increases with each stage of treatment, and often does not resolve even after therapy formally ends. It accompanies therapeutic decisions, waiting for test results, fear of recurrence, and changes in daily functioning. Studies show that chronic stress can trigger biological processes that promote disease progression and weaken the body's defenses.
25
Mar 2026
iXCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences ("Rosebud"), Kantify, and Incite to evaluate off-target chemotherapeutic toxicities in patient-specific organoids.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
